ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

15 links0 made here, not in the record14 judgments1 judge (the rules as one: Rule based)13 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06172296Dinutuximab WithChemotherapy, Surgery andStem Cell Transplantationfor the Treatment ofChildren With NewlyDiagnosed High RiskNeuroblastomaNational Cancer Institute (NCIPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 2 · ClinicalTrials.gov record · Version of 2026-10-02Oct 6 · ClinicalTrials.gov record · Version of 2026-10-06Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Oct 8 · ClinicalTrials.gov record · Version of 2026-10-08Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Oct 14 · ClinicalTrials.gov record · Version of 2026-10-14Oct 16 · ClinicalTrials.gov record · Version of 2026-10-16Oct 19 · ClinicalTrials.gov record · Version of 2026-10-19Oct 20 · ClinicalTrials.gov record · Version of 2026-10-20Oct 21 · ClinicalTrials.gov record · Version of 2026-10-21Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Oct 27 · ClinicalTrials.gov record · Version of 2026-10-27Oct 30 · ClinicalTrials.gov record · Version of 2026-10-30Version of 2026-10-30CONDITIONSGanglioneuroblastomaThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionNeuroblastomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSCarboplatinIntervention entry›As of now · Rule based · BackgroundBackgroundCisplatinIntervention entry›As of now · Rule based · BackgroundBackgroundCyclophosphamideIntervention entry›As of now · Rule based · BackgroundBackgroundDinutuximabIntervention entry›As of now · Rule based · TestedTestedDoxorubicinIntervention entry›As of now · Rule based · BackgroundBackgroundEtoposideIntervention entry›As of now · Rule based · BackgroundBackgroundIrinotecanIntervention entry›As of now · Rule based · BackgroundBackgroundIsotretinoinIntervention entry›As of now · Rule based · BackgroundBackgroundMelphalanIntervention entry›As of now · Rule based · BackgroundBackgroundTemozolomideIntervention entry›As of now · Rule based · BackgroundBackgroundThiotepaIntervention entry›As of now · Rule based · BackgroundBackgroundTopotecanIntervention entry›As of now · Rule based · BackgroundBackgroundVincristineIntervention entry›As of now · Rule based · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Ganglioneuroblastoma

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryGanglioneuroblastoma, as filedthe registry files the study under it
→judged

All judgments on this study

WhenLinkJudgeDecisionState
Oct 2The record itselfClinicalTrials.gov recordVersion of 2026-10-02Record change
Oct 6The record itselfClinicalTrials.gov recordVersion of 2026-10-06Record change
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Oct 8The record itselfClinicalTrials.gov recordVersion of 2026-10-08Record change
Oct 13The record itselfClinicalTrials.gov recordVersion of 2026-10-13Record change
Oct 14The record itselfClinicalTrials.gov recordVersion of 2026-10-14Record change
Oct 16The record itselfClinicalTrials.gov recordVersion of 2026-10-16Record change
Oct 19The record itselfClinicalTrials.gov recordVersion of 2026-10-19Record change
Oct 20The record itselfClinicalTrials.gov recordVersion of 2026-10-20Record change
Oct 21The record itselfClinicalTrials.gov recordVersion of 2026-10-21Record change
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Oct 27The record itselfClinicalTrials.gov recordVersion of 2026-10-27Record change
Oct 30The record itselfClinicalTrials.gov recordVersion of 2026-10-30Record change
As of nowGanglioneuroblastomaRule based · main-condition ruleMain conditionCurrent
As of nowCarboplatinRule based · role ruleBackgroundCurrent
As of nowCisplatinRule based · role ruleBackgroundCurrent
As of nowCyclophosphamideRule based · role ruleBackgroundCurrent
As of nowDinutuximabRule based · role ruleTestedCurrent
As of nowDoxorubicinRule based · role ruleBackgroundCurrent
As of nowEtoposideRule based · role ruleBackgroundCurrent
As of nowIrinotecanRule based · role ruleBackgroundCurrent
As of nowIsotretinoinRule based · role ruleBackgroundCurrent
As of nowMelphalanRule based · role ruleBackgroundCurrent
As of nowTemozolomideRule based · role ruleBackgroundCurrent
As of nowThiotepaRule based · role ruleBackgroundCurrent
As of nowTopotecanRule based · role ruleBackgroundCurrent
As of nowVincristineRule based · role ruleBackgroundCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.